Alexandria® — the world’s largest body of medical evidence for clinical decision support and LLM training.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Planning
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Content
          • Alexandria®
        • Automation Solutions
          • Atropos Evidence™ Agent
          • ChatRWD®
          • Green Button®
          • Forge®
        • Data
          • GENEVA OS®
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
    • Blog
  • Contact Us
  • Login
Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data

Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data

by Julia Rudo | Dec 11, 2025 | Publications

A poster titled, “Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data,” was presented at the American Society of Hematology (ASH) 67th Annual Meeting by authors...
Prior GLP-1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity-matched analysis

Prior GLP-1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity-matched analysis

by Julia Rudo | Dec 8, 2025 | Publications

An article titled, “Prior GLP-1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity-matched analysis,” was published in Society of Hospital Medicine’s Journal of Hospital Medicine by authors Albert K. Park MD, Jason Hom MD, Javier...
Impact of sustained adherence to guideline-directed medical therapy on clinical outcomes in older adults with new-onset heart failure with reduced ejection fraction

Impact of sustained adherence to guideline-directed medical therapy on clinical outcomes in older adults with new-onset heart failure with reduced ejection fraction

by Joy Somogyi | Nov 25, 2025 | Publications

An article titled, “Impact of sustained adherence to guideline-directed medical therapy on clinical outcomes in older adults with new-onset heart failure with reduced ejection fraction,” was published in American Heart Journal Plus: Cardiology Research and Practice by...
Comparison of Fracture Risk Following Semaglutide Treatment vs. Sleeve Gastrectomy

Comparison of Fracture Risk Following Semaglutide Treatment vs. Sleeve Gastrectomy

by Julia Rudo | Nov 10, 2025 | Uncategorized

An article titled, “Comparison of Fracture Risk Following Semaglutide Treatment vs. Sleeve Gastrectomy,” was published in AACE Endocrinology and Diabetes by authors Jairo A. Noreñ, MD, C.William Pike, MD, Gavin Hui, MD, Yasaman Motlaghzadeh, MD-MPH, Deborah E....
Atropos Health Named to Time’s The Best Inventions of 2025

Atropos Health Named to Time’s The Best Inventions of 2025

by Julia Rudo | Oct 9, 2025 | News and Media

ChatRWD®, the generative artificial intelligence (AI) platform from Atropos Health, was named to Time Magazine’s The Best Inventions of 2025. ChatRWD generates actionable insights for providers at the point of care, particularly for underserved populations...
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Planning

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Content

Alexandria®

Automation Solutions

Atropos Evidence™ Agent

ChatRWD®

Green Button®

Forge®

Data

GENEVA OS®

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases
  • Blog

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}